Table 3.
Median (Q1–Q3) | r | p value | |
---|---|---|---|
Socio-demographic characteristics | |||
Sleep quality (PSQI) | |||
Age | 52.50 (40.25–60) | − 0.32 | 0.001 |
Marital status | |||
Married | 7 (4–15) | 0.006 | |
Single/divorced/widow | 13 (7–17) | ||
Have children | |||
No | 17 (12–17) | 0.04 | |
Yes | 7 (4–14) | ||
Medical coverage system | |||
RAmed | 12 (7–17) | 0.000 | |
CNOPS/CNSS | 4 (2–7) | ||
Living area | |||
Rural | 13.5 (7–17) | 0.102 | |
Urban | 11.5 (4–16) | ||
Educational level | |||
None | 12 (6–16) | 0.759 | |
Compulsory school, higher educational degrees | 12 (4.75–16.75) | ||
Working status | |||
Housewives/retired | 10.5 (6–16) | 0.001 | |
Workers | 17 (13–17) | ||
Socio economic status | |||
Poor | 12 (7–17) | 0.001 | |
Good | 4 (3–7) | ||
Clinical characteristics | |||
Surgery | |||
Hysterectomy | 11 (6–16) | 0.111 | |
Oophorectomy | 15 (7–17) | ||
Tumor stage | |||
T1 | 7 (5–16) | 0.689 | |
T2 | 14.5 (4–15.75) | ||
T3 | 12 (7–17) | ||
Time since diagnosis | |||
< 1 an | 13 (7–17) | 0.030 | |
≥ 1 an | 7 (4–15) | ||
Antineoplastic treatment | |||
One treatment | 7 (4–15) | 0.299 | |
Two treatment | 8 (4–17) | ||
Three treatment | 2 (2–2) | ||
Disease recurrence | |||
No | 12 (6–16) | 0.476 | |
Yes | 15 (7–17) |
Values in bold: Significant association (p value < 0.05)
PSQI Pittsburgh Sleep Quality Index, Q1–Q3 interquartile interval
p value obtained with Mann–Whitney U-test and Kruskal–Wallis test